Inventor · disambiguated record
Michael Bradley
Also filed as: BRADLEY MICHAEL · BRADLEY MICHAEL F
30 granted patents·26 pending applications·188 citations·filing 1975–2022
96Inventor score
Top patents by PatentIndex Score
56 records- 0196US7728143B2Salt and crystalline forms thereof of a drugABBOTT LAB·Filed 2005·Granted Jun 1, 2010·13 cites·7 claims
- 0295US8648093B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2012·Granted Feb 11, 2014·7 cites·32 claims
- 0394US10738067B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2020·Granted Aug 11, 2020·5 cites·30 claims
- 0494US8273892B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2010·Granted Sep 25, 2012·9 cites·1 claims
- 0594US8252813B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2010·Granted Aug 28, 2012·10 cites·38 claims
- 0693US11040957B2Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·7 cites·21 claims
- 0792US10059690B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·9 cites·19 claims
- 0892US8969569B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2014·Granted Mar 3, 2015·5 cites·35 claims
- 0991US10047070B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2014·Granted Aug 14, 2018·17 cites·19 claims
- 1085US10106526B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·5 cites·19 claims
- 1185US9539250B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2015·Granted Jan 10, 2017·3 cites·53 claims
- 1284US10906889B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2018·Granted Feb 2, 2021·4 cites·32 claims
- 1384US10519135B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·3 cites·18 claims
- 1483US12240869B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Mar 4, 2025·1 cites·27 claims
- 1583US6774211B1Peptide antiangiogenic drugsABBOTT LAB·Filed 2001·Granted Aug 10, 2004·10 cites·12 claims
- 1682US9873681B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2016·Granted Jan 23, 2018·1 cites·30 claims
- 1780US10329276B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2017·Granted Jun 25, 2019·1 cites·23 claims
- 1875US6777535B1N-alkylated peptides having antiangiogenic activityABBOTT LAB·Filed 2000·Granted Aug 17, 2004·3 cites·38 claims
- 1973US6753408B1Peptides having antiangiogenic activityFiled 2000·Granted Jun 22, 2004·3 cites·29 claims
- 2072US7067490B2Hepta-, Octa-and nonapeptides having antiangiogenic activityABBOTT LAB·Filed 2002·Granted Jun 27, 2006·1 cites·18 claims
- 2171US7001984B2Di-, tri-, and tetra-peptides having antiangiogenic activityABBOTT LAB·Filed 2002·Granted Feb 21, 2006·1 cites·16 claims
- 2267US2007043089A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 2367US2007032527A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 2466US6716963B1Peptide antiangiogenic drugsABBOTT LAB·Filed 1999·Granted Apr 6, 2004·15 cites·42 claims
- 2563US2007167376A1Hexa-, Hepta-, and Octapeptides Having Antiangiogenic ActivityHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 2662US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 2762US3944072AOctagonal dispenser carton for band saw coilsLONGVIEW FIBRE CO·Filed 1975·Granted Mar 16, 1976·28 cites·8 claims
- 2862US2004116479A1Method of inhibiting angiogenesisFiled 2003·Application pending·0 cites
- 2960US2016264551A1Heteroaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3058US7169888B2Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activityABBOTT LAB·Filed 2002·Granted Jan 30, 2007·0 cites·12 claims
- 3158US7122625B2Hexa-, hepta-, and octapeptides having antiangiogenic activityABBOTT LAB·Filed 2002·Granted Oct 17, 2006·0 cites·3 claims
- 3258US2005124548A1Peptide antiangiogenic drugsFiled 2004·Application pending·0 cites
- 3357US2003096758A1HEPTA-, OCTA- and nonapeptides having antiangiogenic activityFiled 2002·Application pending·0 cites
- 3457US2022259195A1Crystalline forms of a cyclin-dependent kinase inhibitorNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 3555US4349105AGun cartonLONGVIEW FIBRE CO·Filed 1981·Granted Sep 14, 1982·26 cites·9 claims
- 3655US2008071062A1Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activityHAVIV FORTUNA·Filed 2007·Application pending·0 cites
- 3754US2003125259A1Octa- and nonapeptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 3853US2006194737A1Hepta-, octa-and nonapeptides having antiangiogenic activityHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 3953US2016264552A1Heteromaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4051US7037897B2TRI-, TETRA-, and penta-peptides having antiangiogenic activityABBOTT LAB·Filed 2002·Granted May 2, 2006·0 cites·13 claims
- 4151US2019292167A1Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4250US2005215484A1Di-, tri-, and tetra-peptides having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 4349US2006030557A1Substituted pyridines having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 4449US2003045477A1Peptides having antiangiogenic activityFiled 2002·Application pending·0 cites
- 4548US2004014744A1Substituted pyridines having antiangiogenic activityFiled 2003·Application pending·0 cites
- 4648US2003119745A1HEXA- and heptapeptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 4747US2003125260A1Tetra-and pentapeptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 4847US2003125261A1Penta- and hexapeptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 4947US2003105025A1Tri-and tetrapeptides having antiangiogenic activityFiled 2001·Application pending·0 cites
- 5046US11918592B2Inhibitors of cyclin dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Mar 5, 2024·0 cites·26 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Bradley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →